Suppr超能文献

脊髓刺激 (SCS) 结合解剖引导 (3D) 神经靶向治疗与传统 SCS-LUMINA 研究相比,在慢性轴向腰痛缓解方面具有优势。

Spinal Cord Stimulation (SCS) with Anatomically Guided (3D) Neural Targeting Shows Superior Chronic Axial Low Back Pain Relief Compared to Traditional SCS-LUMINA Study.

机构信息

Case Western Reserve Medical Center, Cleveland, Ohio.

Louis Stokes VA Medical Center, Cleveland, Ohio.

出版信息

Pain Med. 2017 Aug 1;18(8):1534-1548. doi: 10.1093/pm/pnw286.

Abstract

BACKGROUND

The aim of this study was to determine whether spinal cord stimulation (SCS) using 3D neural targeting provided sustained overall and low back pain relief in a broad routine clinical practice population.

STUDY DESIGN AND METHODS

This was a multicenter, open-label observational study with an observational arm and retrospective analysis of a matched cohort. After IPG implantation, programming was done using a patient-specific, model-based algorithm to adjust for lead position (3D neural targeting) or previous generation software (traditional). Demographics, medical histories, SCS parameters, pain locations, pain intensities, disabilities, and safety data were collected for all patients.

RESULTS

A total of 213 patients using 3D neural targeting were included, with a trial-to-implant ratio of 86%. Patients used seven different lead configurations, with 62% receiving 24 to 32 contacts, and a broad range of stimulation parameters utilizing a mean of 14.3 (±6.1) contacts. At 24 months postimplant, pain intensity decreased significantly from baseline (ΔNRS = 4.2, N = 169, P  < 0.0001) and even more in in the severe pain subgroup (ΔNRS = 5.3, N = 91, P  < 0.0001). Axial low back pain also decreased significantly from baseline to 24 months (ΔNRS = 4.1, N = 70, P  < 0.0001, on the overall cohort and ΔNRS = 5.6, N = 38, on the severe subgroup). Matched cohort comparison with 213 patients treated with traditional SCS at the same centers showed overall pain responder rates of 51% (traditional SCS) and 74% (neural targeting SCS) and axial low back pain responder rates of 41% and 71% in the traditional SCS and neural targeting SCS cohorts, respectively. Lastly, complications occurred in a total of 33 of the 213 patients, with a 1.6% lead replacement rate and a 1.6% explant rate.

CONCLUSIONS

Our results suggest that 3D neural targeting SCS and its associated hardware flexibility provide effective treatment for both chronic leg and chronic axial low back pain that is significantly superior to traditional SCS.

摘要

背景

本研究旨在确定在广泛的常规临床实践人群中,使用三维神经靶向的脊髓刺激(SCS)是否能持续缓解整体和下腰痛。

研究设计与方法

这是一项多中心、开放性、观察性研究,包括观察臂和匹配队列的回顾性分析。在植入 IPG 后,使用基于患者特定模型的算法进行编程,以调整导联位置(三维神经靶向)或上一代软件(传统方法)。所有患者均收集人口统计学、病史、SCS 参数、疼痛部位、疼痛强度、残疾和安全性数据。

结果

共纳入 213 例使用三维神经靶向的患者,试验到植入的比例为 86%。患者使用了七种不同的导联配置,其中 62%的患者接受了 24 到 32 个触点,刺激参数范围广泛,平均使用 14.3(±6.1)个触点。植入后 24 个月,疼痛强度与基线相比显著下降(ΔNRS=4.2,N=169,P<0.0001),在重度疼痛亚组中下降更为明显(ΔNRS=5.3,N=91,P<0.0001)。轴向腰痛也从基线到 24 个月显著下降(ΔNRS=4.1,N=70,P<0.0001,在总体队列中;ΔNRS=5.6,N=38,在重度亚组中)。与同一中心的 213 例接受传统 SCS 治疗的患者进行匹配队列比较,传统 SCS 组的总疼痛缓解率为 51%(传统 SCS)和 74%(神经靶向 SCS),传统 SCS 组和神经靶向 SCS 组的轴向腰痛缓解率分别为 41%和 71%。最后,213 例患者中共有 33 例发生并发症,其中 1.6%的导联更换率和 1.6%的取出率。

结论

我们的结果表明,三维神经靶向 SCS 及其相关硬件灵活性为慢性下肢和慢性轴向腰痛提供了有效治疗,其效果明显优于传统 SCS。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验